Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
OPOGDZANLATWGS
|
6.3 | Ki | 9 | — | |
PHWHNHYZZNJPLB
|
6.3 | Ki | 16 | — | |
PQNWNVWJXPSZFR
|
6.3 | Ki | 21 | — | |
PYQFQGXOARMGAQ
|
6.3 | IC50 | 11 | — | |
QUZYEJUYJAWLOF
|
6.3 | Ki | 4 | — | |
SDBOIBYRBWPIEL
|
6.3 | Ki | 31 | — | |
SRUYMJRFVGLQDV
|
6.3 | Ki | 37 | — | |
UNVKXVCDLOLPJE
|
6.3 | Ki | 8 | — | |
UUWNXFJBBYAMDT
|
6.3 | Ki | 46 | — | |
WXUJAQBSBZLVEV
|
6.3 | IC50 | 3 | Yes | |
XMBGRSAVBPRZAS
|
6.3 | IC50 | 2 | — | |
XONRTPBYDAFIRW
|
6.3 | IC50 | 9 | — | |
XWKMAJPZELTMLH
|
6.3 | IC50 | 2 | Yes | |
BIUSOGXDWCLKOI
|
6.3 | IC50 | 2 | — | |
NCKLQXXBRWCYMA
|
6.3 | IC50 | 2 | — | |
QQNWTHYCTZYQSU
|
6.3 | IC50 | 2 | — | |
QXFBTYPBHYOEMX
|
6.3 | IC50 | 9 | — | |
UXMOTLPQGDBXOT
|
6.3 | IC50 | 2 | — | |
AETSHOXDYIPJJZ
|
6.3 | IC50 | 3 | Yes | |
DCBGVRDAEOIKPQ
|
6.3 | Ki | 5 | Yes | |
FEFPSHIDVWKVSO
|
6.3 | IC50 | 4 | — | |
HNTUWEZDVRVSFY
|
6.3 | IC50 | 2 | — | |
HTMPLNGIKKRYHY
|
6.3 | IC50 | 2 | — | |
KHBDUFVSCOBDHC
|
6.3 | IC50 | 2 | — | |
MVYPUOKVRYWDOJ
|
6.3 | Ki | 2 | — | |
OGZGOMXAESDRGG
|
6.3 | IC50 | 2 | — | |
OQJKZGGGSJDJQX
|
6.3 | IC50 | 3 | Yes | |
RLAJOHAIIACFAM
|
6.3 | IC50 | 13 | Yes | |
VDOHDCXDESGVKC
|
6.3 | IC50 | 8 | — | |
FCAPBPOVJUMQEJ
|
6.3 | IC50 | 4 | — | |
LAYJBNYAZAHOBZ
|
6.3 | IC50 | 2 | — | |
MTNBRBDFNSGQKB
|
6.3 | Ki | 10 | — | |
PFHKAGAZRDERTK
|
6.3 | Ki | 4 | Yes | |
QVCLVTVRXGXXOR
|
6.3 | IC50 | 4 | — | |
RAXZSEGXMBWYQK
|
6.3 | IC50 | 21 | — | |
RTDKCTPKXLRSLL
|
6.3 | IC50 | 2 | — | |
VSVKFEMFAYXZKR
|
6.3 | Ki | 14 | Yes | |
ACDUVLIHPXIHRC
|
6.3 | IC50 | 2 | — | |
ACQZMAJVOPRMQJ
|
6.3 | IC50 | 2 | — | |
AEJUGNOCBAARIW
|
6.3 | IC50 | 2 | — | |
AEJUGNOCBAARIW
|
6.3 | IC50 | 2 | — | |
AIXCZRWRLBSHSQ
|
6.3 | IC50 | 2 | — | |
AJRILXIGHKWAAG
|
6.3 | IC50 | 2 | — | |
AKLSXSNSFBGKRD
|
6.3 | IC50 | 2 | — | |
ALDWMGWKZGUAEE
|
6.3 | IC50 | 2 | — | |
AQHAMSAAXCMDHR
|
6.3 | IC50 | 2 | — | |
ARUTYOPVIKUZFI
|
6.3 | IC50 | 2 | — | |
ATYDVYRSYHPQPG
|
6.3 | IC50 | 2 | — | |
AULZEGRFESKHNL
|
6.3 | IC50 | 2 | — | |
AZVZBWLBRBDKMD
|
6.3 | IC50 | 2 | — |